HemoShear Co-Founder Testifies on Tech Transfer at Congressional Hearing
Monday, August 19, 2013
Dr. Brian R. Wamhoff, co-founder of HemoShear, was the only industry
representative invited to present his recommendations on improvements to
the U. S. government's Small Business Technology Transfer program to
stimulate translation of new discoveries from academia to the
marketplace. Dr. Wamhoff's testimony was given at a hearing of the U.S.
House of Representatives Committee on Science, Engineering and
Technology for the purpose of guiding the draft of new legislation
entitled "Innovative Approaches to the Technology Transfer Act of 2013".
transitioned recently from academic researcher to entrepreneur, I
benefitted from the creativity and resources that academic environments
provide, while also encountering cultural challenges of translating a
new technology from a university lab to a commercial enterprise. My
fellow academic researchers would benefit from appropriate incentives to
translate their science, yet at the same time they need structure and
accountability," said Dr. Wamhoff.
The draft legislation,
supported by Wamhoff will create a program to incentivize research
institutions to implement innovative approaches to technology transfer
to achieve better outcomes. The legislation would dedicate a portion of
STTR program funding to provide grants to research institutions to help
facilitate and accelerate the transfer of federally funded research and
technology into the marketplace.
Dr. Wamhoff's testimony and
further information on the Committee's activities regarding the Small
Business Technology Transfer program may be found at the following